Skip to main content
Optipharm.CO.,LTD logo

Optipharm.CO.,LTD — Investor Relations & Filings

Ticker · 153710 ISIN · KR7153710009 KO Professional, scientific and technical activities
Open in API
Filings indexed 177 across all filing types
Latest filing 2025-06-10 Director's Dealing
Country KR South Korea
Listing KO 153710

About Optipharm.CO.,LTD

https://www.optipharm.co.kr

Optipharm is a biomedical company specializing in animal health solutions and advanced biotherapeutics. The company's core activities encompass animal disease diagnosis, the development and sale of veterinary pharmaceuticals, and the creation of bacteriophage-based treatments. A key focus is on preventative medicine, including the research and development of Virus-Like Particle (VLP) vaccines and a nanoparticle-based vaccine for Foot-and-Mouth Disease. In the biomedical sector, Optipharm is advancing xenotransplantation through its 'Medipig' platform for developing xenogeneic organs and tissues. The company also produces transgenic animal models for research and develops cell therapy products using animal stem cells, with a long-term strategy to transition its innovations to human medicine.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kim Hyun-il) of Optipharm. This type of filing, which details personal share transactions by company directors and executives, is classified as a Director's Dealing (DIRS) report.
2025-06-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the acquisition of shares by a company executive (Kim Hyun-il of Optipharm) through open market purchases. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider transactions by company management.
2025-05-19 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Optipharm' (주식회사 옵티팜) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
[기재정정]투자판단관련주요경영사항 (민군겸용 기술개발사업(형질전환돼지 기반 수혈가능 이종적혈구제제 기술개발) 국책과제 선정)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system (KIND) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Major Management Matter' (투자판단 관련 주요경영사항). It details a change in the budget for a government-funded research project (민군겸용 기술개발사업). Since this is a formal regulatory announcement of a material change to a previously filed business matter, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Dividends, or Earnings Releases.
2025-05-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions (insider trading). According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2025-04-11 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (Annual General Meeting). It details the voting outcomes for agenda items such as financial statement approval, director appointments, and other resolutions. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.